- Institut de Recerca Biomèdica de Lleida (IRB-Lleida)
Research institute
Hospital Virgen del Camino
Pamplona, EspañaPublications in collaboration with researchers from Hospital Virgen del Camino (37)
2024
-
Vaccine–carditis study: Spanish multicenter registry of inflammatory heart disease after COVID-19 vaccination
Clinical Research in Cardiology, Vol. 113, Núm. 2, pp. 223-234
2023
-
Total neoadjuvant therapy with or without aflibercept in rectal cancer: 3-year results of GEMCAD-1402
Journal of the National Cancer Institute, Vol. 115, Núm. 12, pp. 1497-1505
2022
-
Ischemia preconditioning induces an adaptive response that defines a circulating metabolomic signature in ischemic stroke patients
Journal of Cerebral Blood Flow and Metabolism, Vol. 42, Núm. 12, pp. 2201-2215
-
The Effect of Enteral Immunonutrition in the Intensive Care Unit: Does It Impact on Outcomes?
Nutrients, Vol. 14, Núm. 9
2021
-
Clinical impact of presurgery circulating tumor DNA after total neoadjuvant treatment in locally advanced rectal cancer: A biomarker study from the GEMCAD 1402 trial
Clinical Cancer Research, Vol. 27, Núm. 10, pp. 2890-2898
-
Use of cardiovascular polypills for the secondary prevention of cerebrovascular disease
Neurologia, Vol. 36, Núm. 1, pp. 1-8
2020
-
Association of a single nucleotide polymorphism combination pattern of the Klotho gene with non-cardiovascular death in patients with chronic kidney disease
Clinical Kidney Journal, Vol. 13, Núm. 6, pp. 1017-1024
-
Inflammatory Response of Ischemic Tolerance in Circulating Plasma: Preconditioning-Induced by Transient Ischemic Attack (TIA) Phenomena in Acute Ischemia Patients (AIS)
Frontiers in Neurology, Vol. 11
2019
-
Association of candidate gene polymorphisms with chronic kidney disease: Results of a case-control analysis in the NEFRONA cohort
Frontiers in Genetics, Vol. 10, Núm. FEB
-
Economics of gastroenteropancreatic neuroendocrine tumors: a systematic review
Therapeutic Advances in Endocrinology and Metabolism, Vol. 10
-
Effect of Aflibercept Plus Modified FOLFOX6 Induction Chemotherapy before Standard Chemoradiotherapy and Surgery in Patients with High-Risk Rectal Adenocarcinoma: The GEMCAD 1402 Randomized Clinical Trial
JAMA Oncology, Vol. 5, Núm. 11, pp. 1566-1573
-
Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial
Cancer Chemotherapy and Pharmacology, Vol. 83, Núm. 6, pp. 1175-1181
2018
-
Prognostic factors and analysis of mortality due to brain haemorrhages associated with vitamin K antagonist oral anticoagulants. Results from the TAC registry
Neurologia, Vol. 33, Núm. 7, pp. 419-426
-
Statins do not increase Markers of Cerebral Angiopathies in patients with Cardioembolic Stroke
Scientific Reports, Vol. 8, Núm. 1
-
Subcutaneous panniculitis-like T-cell lymphoma: Clinical features, therapeutic approach, and outcome in a case series of 16 patients
Journal of the American Academy of Dermatology, Vol. 79, Núm. 5, pp. 892-898
2017
-
Dynamic soluble changes in sVEGFR1, HGF, and VEGF promote chemotherapy and bevacizumab resistance: A prospective translational study in the BECOX (GEMCAD 09-01) trial
Tumor Biology, Vol. 39, Núm. 6
-
Evidence of an epistatic effect between Dysbindin-1 and Neuritin-1 genes on the risk for schizophrenia spectrum disorders
European Psychiatry, Vol. 40, pp. 60-64
-
Familial aggregation of schizotypy in schizophrenia-spectrum disorders and its relation to clinical and neurodevelopmental characteristics
Journal of Psychiatric Research, Vol. 84, pp. 214-220
-
GRECOS Project (Genotyping Recurrence Risk of Stroke): The Use of Genetics to Predict the Vascular Recurrence after Stroke
Stroke, Vol. 48, Núm. 5, pp. 1147-1153
-
Role of total tumour load of sentinel lymph node on survival in early breast cancer patients
Breast, Vol. 33, pp. 8-13